^
    1year
    Efficacy and Safety of PVT-1 Treatment in Patients With Advanced Non-Small Cell Lung Cancer (clinicaltrials.gov)
    P2, N=24, Recruiting, PlusVitech S.L. | Trial completion date: Dec 2022 --> Dec 2025 | Trial primary completion date: Dec 2022 --> Dec 2025
    Trial completion date • Trial primary completion date • Metastases
    |
    EGFR (Epidermal growth factor receptor) • ROS1 (Proto-Oncogene Tyrosine-Protein Kinase ROS)
    |
    PVT-1